The Global Virus Network said on April 3 that the emerging SARS-CoV-2 variant BA.3.2, sometimes called the "cicada" variant in media reports, does not currently pose a greater danger or require heightened public concern.
The announcement comes as scientists continue to track BA.3.2, which is a sublineage of the Omicron variant of SARS-CoV-2, through international genomic surveillance systems. Early analyses by public health authorities and laboratory studies show that while BA.3.2 has mutations in its spike protein allowing it to partially escape antibodies, this does not mean people are less protected from severe illness if infected.
"While immune escape may increase the likelihood of infection or reinfection, it does not imply reduced protection against severe disease," the Global Virus Network said in its statement.
Currently, there is no evidence linking BA.3.2 with increased severity of disease or higher rates of transmission at a population level compared to previous variants.
The group also clarified that the nickname "cicada" is informal and unrelated to any scientific naming system or biological connection with insects; it refers only to how the variant seemed to reappear after a period when it was rarely detected.
Officials from the Global Virus Network emphasized ongoing vigilance as essential but reiterated that current guidance remains unchanged for individuals: established public health measures should continue to be followed while experts monitor developments related to this and other emerging variants.
